基于基于机器学习的RNA结合蛋白的整合模型,确定DDX56的关键瘤机制
Hui Jiang1,2, Haotian Zheng1,2, Xinjie Zhao1,2
1Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
NPJ precision oncology
|July 16, 2025
概括
这项研究使用机器学习识别了肺腺癌 (LUAD) 中的关键RNA结合蛋白 (RBPs). 一个新的风险模型强调DDX56作为潜在的治疗点,影响患者的预后和治疗反应.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- RNA结合蛋白 (RBPs) 对细胞过程至关重要,它们的失调在癌症中很常见.
- 在肺腺癌 (LUAD) 中RBPs的特定作用仍未得到充分研究.
- 开发强大的预后模型对于改善LUAD患者的治疗结果至关重要.
研究的目的:
- 系统地研究预后RNA结合蛋白 (RBPs) 在肺腺癌 (LUAD) 中的作用.
- 开发和验证基于机器学习的风险模型,用于预测LUAD患者的预后.
- 确定特定的RBP,如DDX56,并阐明它们在LUAD进展中的功能机制.
主要方法:
- 利用机器学习整合程序在LUAD中选枢纽预测RBPs.
- 基于已识别的RBPs开发了一个风险模型,并对其性能与现有签名进行评估.
- 研究了DDX56在LUAD细胞中的功能作用,包括其对细胞亡,药物敏感性和信号通路的影响.
主要成果:
- 与103个已发布的签名相比,开发的机器学习风险模型显示出卓越的性能 (高C指数).
- 高风险组的患者表现出较低的免疫评分和较差的免疫治疗反应.
- DDX56,一种RNA酶,被确定为一个关键的预后RBP,通过调节Bcl-2并激活LUAD中的NF-kB信号来促进扩散,迁移和入侵.
结论:
- 一个新的机器学习衍生风险模型有效预测LUAD预后和免疫治疗反应.
- DDX56通过促进细胞存活,增殖和转移,在LUAD病变发生中发挥着重要作用.
- DDX56是改善肺腺癌治疗策略的潜在治疗标.
相关概念视频
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


